ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
Jung, Hae-Yun, Lee, Dae-Keum, Lee, Minwook, Choi, Seung Hee, Park, Joo Dong, Ko, Eun-Su, Lee, Jongwon, Park, Kyung-Soon, Jung, Hae-Yun
Published in Oncoimmunology (31.12.2023)
Published in Oncoimmunology (31.12.2023)
Get full text
Journal Article
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
Park, Joo Dong, Kim, Kwang-Soo, Choi, Seung Hee, Jo, Gae Hoon, Choi, Jin-Ho, Park, Si-Won, Ko, Eun-Su, Lee, Minwook, Lee, Dae-Keum, Jang, Hye Jung, Hwang, Sohyun, Jung, Hae-Yun, Park, Kyung-Soon
Published in Journal for immunotherapy of cancer (01.07.2022)
Published in Journal for immunotherapy of cancer (01.07.2022)
Get full text
Journal Article
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy
Choi, Seung Hee, Kim, Hye Jin, Park, Joo Dong, Ko, Eun-Su, Lee, Minwook, Lee, Dae-Keum, Choi, Jin-Ho, Jang, Hye Jung, Kim, Isaac, Jung, Hae-Yun, Park, Keun-Hong, Park, Kyung-Soon
Published in Journal for immunotherapy of cancer (01.08.2022)
Published in Journal for immunotherapy of cancer (01.08.2022)
Get full text
Journal Article